Connection
Matthew Ellis to Neoplasms, Hormone-Dependent
This is a "connection" page, showing publications Matthew Ellis has written about Neoplasms, Hormone-Dependent.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.371 |
|
|
|
-
Ma CX, Bose R, Ellis MJ. Prognostic and Predictive Biomarkers of Endocrine Responsiveness for Estrogen Receptor Positive Breast Cancer. Adv Exp Med Biol. 2016; 882:125-54.
Score: 0.464
-
Ma CX, Crowder RJ, Ellis MJ. Importance of PI3-kinase pathway in response/resistance to aromatase inhibitors. Steroids. 2011 Jul; 76(8):750-2.
Score: 0.333
-
Ellis MJ, Ma C. Letrozole in the neoadjuvant setting: the P024 trial. Breast Cancer Res Treat. 2007; 105 Suppl 1:33-43.
Score: 0.262
-
Ma CX, Ellis MJ. Neoadjuvant endocrine therapy for locally advanced breast cancer. Semin Oncol. 2006 Dec; 33(6):650-6.
Score: 0.247
-
Ellis M, Ma C. Femara and the future: tailoring treatment and combination therapies with Femara. Breast Cancer Res Treat. 2007; 105 Suppl 1:105-15.
Score: 0.065